05:38:15 EDT Fri 29 Mar 2024
Enter Symbol
or Name
USA
CA



AMP German Cannabis Group Inc
Symbol XCX
Shares Issued 20,217,796
Close 2019-10-07 C$ 0.32
Market Cap C$ 6,469,695
Recent Sedar Documents

AMP German signs MOU to buy 1,200 kg/yr of cannabis

2019-10-08 06:25 ET - News Release

Mr. Alex Blodgett reports

AMP GERMAN CANNABIS GROUP ENTERS INTO MEMORANDUM OF UNDERSTANDING SUPPLY AGREEMENT FOR THE IMPORT OF EU-GMP MEDICAL CANNABIS INTO GERMANY

AMP German Cannabis Group Inc. has entered into a non-binding memorandum of understanding to purchase up to 1,200 kilograms of either branded or white-labelled European Union good manufacturing practice (EU-GMP) medical cannabis flower annually from an Alberta-based supplier with a cultivation and processing licence from Health Canada.

AMP and the Alberta LP will begin imports upon the Alberta LP receiving a sales licence from Health Canada and receiving EU-GMP certification by German state officials.

EU-GMP certification is an internationally recognized system that ensures all pharmaceutical goods, including medical cannabis, meet the highest consumer health and safety standards. Canadian licensed producers of cannabis production and operating processes do not meet EU-GMP standards and need to be upgraded and receive EU-GMP certification from a German state before being able to export to Germany.

Management quotes

Alex Blodgett, chief executive officer of AMP German Cannabis Group, commented: "Aurora Cannabis, which was awarded a German cultivation licence, and other small- to medium-sized cannabis producers have made the Alberta region into a major cannabis production cluster in Canada. This is AMP's second supply agreement with an Alberta region supplier focused on supplying Germany with EU-GMP cannabis."

Dr. Stefan Feuerstein, managing director of Alternative Medical Products GmbH, commented, "AMP expects to close further supply agreements before year-end in addition to receiving our narcotic licence to import medical cannabis into Germany."

About AMP German Cannabis Group Inc.

AMP German Cannabis Group is the parent company of several European investment subsidiaries focusing on the import of pharmaceutical-grade (EU-GMP) cannabis into Germany predominantly from Canada. AMP provides EU-GMP gap analysis and audits, logistical, transportation, importation permits, and other related services for the importation of medical cannabis into Germany through its AMP EU-GMP German certification protocol program.

We seek Safe Harbor.

© 2024 Canjex Publishing Ltd. All rights reserved.